MustGrow Biologics Corp. · TSXV:MGRO
MustGrow Biologics — Investor Presentation (November 2026)
11 slides from MustGrow Biologics's investor presentation, November 2026
Slide 1: Providing High Growth Regenerative Agriculture Solutions
Providing High Growth Regenerative Agriculture Solutions Corporate Presentation TSXV: MGRO OTCQB: MGROF November 2026 FRA: 0C0
Slide 2: Disclaimer
Disclaimer This presentation is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities of MustGrow Biologics Corp. (“MustGrow”) nor shall there be any sale of securities in any jurisdicti
Slide 3: MustGrow is a provider of biological products & technologies derived from mustard
MustGrow is a provider of biological products & technologies that are derived from mustard to support sustainable farming The #1 thing every farmer Commercial cares about is growing a Massive Market Partnership • US$380 billion (2032 crop and protecting it from est.) global fertilizer & • Estimating
Slide 4: Sustainable Agriculture is the Future of Food Security
Sustainable Agriculture is the Future of Food Security Increased Regulation on … Commitment to Organic Large and Growing Global Demand for Synthetic Chemicals… Solutions & Growth Natural Biologics (estimated 2032) The consolidated list of banned pesticides lists 568 Bayer expects to access more than
Slide 5: Using Extracts from Mustard to Create Agriculture Products
Using Extracts from Mustard to Create Agriculture Products Mustard Seed Meal MustGro Invest (EPA Reg. No. 87862-1) Crushed seed with oil removed Bulky, inefficient Registered Biofertility Product Pre-Registered Biocontrol Product Registered in key US-states Active ingredient is AITC to
Slide 6: MustGrow's Commercial Sales Expansion is in Process
MustGrow’s Commercial Sales Expansion is in Process Commercialized Pre-registered Products & Technologies • MustGrow owned • Biocontrol in ROW • Seeking fast-track biofertility product in • US$850M* registrations in other the US countries around the world • 2.0% of acres • US$100M* • Testing in The
Slide 7: TerraSante Biofertility: U.S. Sales Strategy
TerraSanteTM Biofertility: U.S. Sales Strategy Registered in Key States Targeting High Value Crops • California, Florida, Arizona, Idaho, Oregon, Washington, • Fruit & vegetables; tree, nut & vine; root & tuber; potatoes Georgia, etc. • 5.6 million acres (187,000 acres of organic) in the US* • Organ
Slide 8: Partnering with Manufactures for Production
Partnering with Manufactures for Production Asset-Light Estimated Grower Level Revenue Opportunity MustGrow has a CURRENT ACTIONABLE viable production plan that can ramp Production Capacity (tonnes of TerraSanteTM) ~550 ~2,000-3,900 up significantly as the Potential Revenue (CAD) $20M $50-100M busin
Slide 9: Capital Structure
TSXV:MGRO Capital Structure OTCQB:MGROF FRA:0C0 Common Shares Outstanding 70,441,359 Warrants 16,862,730 Options/RSUs/DSUs 5,803,901 Convertible debentures 133,332 Fully-Diluted Shares Outstanding 93,241,322 Market Cap (CAD) $30,000,000 Mgmt. & Advisor Ownership 17% Average Volume (3 month) 45,000 P
Slide 10: Experienced Management Team
Experienced Management Team Lean executive team has the vision, energy and experience to execute Kevin Helash Colin Bletsky President & CEO CCO • 30+ Years Experience • 8 years with Company • 30+ Years Experience Corey Giasson, MBA Todd Lahti, CFA, CPA, CA COO CFO • 8 years with Company • 13 years w
Slide 11: Experienced Board of Directors & Advisors
Experienced Board of Directors & Advisors Board of Directors Brad Munro 1, 2 David Borecky, CPA, CA 1, 2 Tom Flow 1, 3 Corey Giasson Chairman Director Director Director Laura Westby, JD 1, 2, 3 Matt Kowalski1, 3 Kevin Helash Director Colin Bletsky Director Director Director 1 Independent 2 Audit Com
MustGrow Biologics — Investor Presentation (November 2026) on 6ix